Here's why Indoco Remedies shares were under pressure on March 11; details

Q: How long will it take to read this news story?

The story "Here&#039;s why Indoco Remedies shares were under pressure on March 11; details" has 460 words across 19 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Here&#039;s why Indoco Remedies shares were under pressure on March 11; details" was covered 1 days ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 279 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #26879143</li><li>URL: https://beamstart.com/news/heres-why-indoco-remedies-shares-17416689155298</li></ul>

Business Standard Logo Business Standard 1d ago

Here's why Indoco Remedies shares were under pressure on March 11; details - Business Standard

Quick Summary:

It also operates 8 domestic marketing divisions and boasts a strong brand portfolio in therapeutic areas such as Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management, and Gynaecology.

With an annual turnover of $212 million and a workforce of over 6,000 employees, including more than 400 skilled scientists and field staff, the company is backed by a strong human capital foundation.

Moreover, Indoco Remedies develops and manufactures a wide array of pharmaceutical products catering to both the Indian and international markets.